Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
GLP-1 agonists may also have benefits for heart health, with research suggesting that they can reduce the risk of strokes, heart attacks, and death caused by cardiovascular disease by 20% compared to a placebo
GLP-1, acting on its receptor, has physiological actions on multiple target organs: it increases glucose-stimulated insulin secretion in pancreatic beta cells, reduces glucagon secretion by cells, improves insulin sensitivity and reduces food intake.26 In cellular and murine models GLP-1 promotes cell neogenesis and inhibits their apoptosis.27 Insulin secretion induced by GLP-1 is dependent of the glycemia and therefore does not induce hypoglycemia (Fig
"There is some data out there, but in pre-clinical models
When you place these two compounds side-by-side, the distinctions become crystal clear
This is no different with Mounjaro and Wegovy
